BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perdawood SK, Kroeigaard J, Eriksen M, Mortensen P. Transanal total mesorectal excision: the Slagelse experience 2013-2019. Surg Endosc. 2020;. [PMID: 32072292 DOI: 10.1007/s00464-020-07454-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Perdawood SK, Neufert RS, Kroeigaard J, Maina PJ, Eiholm S, Jörgren F, Buchwald P. Low presence of intraluminal cancer cells in rectal washout during transanal total mesorectal excision. Br J Surg 2021;108:e338-9. [PMID: 34453439 DOI: 10.1093/bjs/znab256] [Reference Citation Analysis]
2 Hahn SJ, Sylla P. Technological Advances in the Surgical Treatment of Colorectal Cancer. Surgical Oncology Clinics of North America 2022;31:183-218. [DOI: 10.1016/j.soc.2022.01.001] [Reference Citation Analysis]
3 Ourô S, Albergaria D, Ferreira MP, Costeira B, Roquete P, Ferreira D, Maio R. Transanal total mesorectal excision: 3-year oncological outcomes. Tech Coloproctol 2021;25:205-13. [PMID: 33113009 DOI: 10.1007/s10151-020-02362-y] [Reference Citation Analysis]
4 Caycedo-Marulanda A, Lee L, Chadi SA, Verschoor CP, Crosina J, Ashamalla S, Brown CJ; Canadian taTME Expert Collaboration. Association of Transanal Total Mesorectal Excision With Local Recurrence of Rectal Cancer. JAMA Netw Open 2021;4:e2036330. [PMID: 33533932 DOI: 10.1001/jamanetworkopen.2020.36330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Caycedo-Marulanda A, Patel S, Merchant S, Brown C. Introduction of new techniques and technologies in surgery: Where is transanal total mesorectal excision today? World J Gastrointest Surg 2020; 12(5): 203-207 [PMID: 32551026 DOI: 10.4240/wjgs.v12.i5.203] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Aigner F, Dittrich L, Schmuck R, Pratschke J, Biebl M. [Transanal total mesorectal excision-Indications, technique and results]. Chirurg 2020;91:860-9. [PMID: 32583027 DOI: 10.1007/s00104-020-01223-6] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gardner IH, Kelley KA, Abdelmoaty WF, Sharata A, Hayman AV, Whiteford MH. Transanal total mesorectal excision outcomes for advanced rectal cancer in a complex surgical population. Surg Endosc 2021. [PMID: 33416990 DOI: 10.1007/s00464-020-08251-7] [Reference Citation Analysis]
8 González-Abós C, de Lacy FB, Guzmán Y, Nogueira ST, Otero-Piñeiro A, Almenara R, Lacy AM. Transanal total mesorectal excision for stage II or III rectal cancer: pattern of local recurrence in a tertiary referral center. Surg Endosc 2021. [PMID: 33398553 DOI: 10.1007/s00464-020-08200-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Dittrich L, Biebl M, Schmuck R, Gül S, Weiss S, Haase O, Knoop M, Alkatout I, Pratschke J, Aigner F. Initial Experience with the Safe Implementation of Transanal Total Mesorectal Excision (TaTME) as a Standardized Procedure for Low Rectal Cancer. J Clin Med 2020;10:E72. [PMID: 33379270 DOI: 10.3390/jcm10010072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hallam S, Ahmed F, Gouvas N, Pandey S, Nicol D. Oncological outcomes and stoma-free survival following TaTME, a prospective cohort study. Tech Coloproctol 2021;25:439-47. [PMID: 33606129 DOI: 10.1007/s10151-020-02390-8] [Reference Citation Analysis]
11 Zeng Z, Liu Z, Luo S, Liang Z, Huang L, Ruan L, Chen J, Jie H, Liang W, Liu H, Kang L. Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer. Surg Endosc 2021. [PMID: 34448933 DOI: 10.1007/s00464-021-08707-4] [Reference Citation Analysis]
12 Van Oostendorp SE, Belgers HJE, Hol JC, Doornebosch PG, Belt EJT, Oosterling SJ, Kusters M, Bonjer HJJ, Sietses C, Tuynman JB. The learning curve of transanal total mesorectal excision for rectal cancer is associated with local recurrence: results from a multicentre external audit. Colorectal Dis 2021;23:2020-9. [PMID: 33969621 DOI: 10.1111/codi.15722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wasmuth HH, Gachabayov M, Bokey L, Fingerhut A, Orangio GR, Remzi FH, Bergamaschi R. Statistical, Clinical, Methodological Evaluation of Local Recurrence Following Transanal Total Mesorectal Excision for Rectal Cancer: A Systematic Review. Dis Colon Rectum 2021;64:899-914. [PMID: 33938532 DOI: 10.1097/DCR.0000000000002110] [Reference Citation Analysis]
14 Vannijvel M, Wolthuis AM. Limitations and Concerns with Transanal Total Mesorectal Excision for Rectal Cancer. Clin Colon Rectal Surg 2022;35:141-5. [PMID: 35237110 DOI: 10.1055/s-0041-1742115] [Reference Citation Analysis]